Target intelligence / Profile preview

Adaptive Immune System Components

Molecular classification
Other
01

Overview

“Adaptive Immune System Components” refers to the major cellular and molecular machinery responsible for specific, acquired immunity in vertebrates. The principal cellular components are **B cells** (B lymphocytes) and **T cells** (T lymphocytes), both of which arise from hematopoietic stem cells[1][7]. B cells mediate humoral immunity by producing antibodies (immunoglobulins) which neutralize pathogens and facilitate their clearance[4][6][7]. T cells comprise several subtypes: helper T cells (orchestrate immune responses via cytokine signaling), cytotoxic T cells (kill infected or malignant cells), and regulatory/memory T cell subsets[1][5][8]. These lymphocytes recognize antigens through highly variable, somatically rearranged receptors (B cell receptor [BCR] for B cells, T cell receptor [TCR] for T cells), enabling precise and diverse antigen recognition[3][7]. The adaptive immune system also possesses memory, providing faster and stronger responses to previously encountered antigens. However, “Adaptive Immune System Components” is not a single molecular entity or defined drug target—it encompasses a range of cells, receptors, and proteins such as *immunoglobulin classes* (IgG, IgA, IgM, etc.), T cell coreceptors (CD4, CD8), and MHC molecules[4][6]. Each of these could serve as an individual target, but the overall system is too broad and complex to be classified as a single molecular target for drug development[7][1].

Other names
Adaptive immunityAcquired immune systemHumoral and cell-mediated immune responseB lymphocyte and T lymphocyte immune response
02

Biological functions

Immune responsePathogen recognitionMemory generationAntibody productionCytotoxic cell-mediated killing
03

Disease associations

InfectionCancerInflammationAutoimmune diseaseAllergy
04

Safety considerations

Overactivation may lead to autoimmunity or allergies[3].Immunodeficiency increases risk of infection[6].

Beyond the preview

Go deeper on Adaptive Immune System Components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adaptive Immune System Components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call